Krima Agravat

Contributed to the development and maintenance of Global Value Dossiers (GVDs) by synthesizing clinical and health economic evidence from systematic literature reviews into clear, payer-relevant value narratives. Supported value demonstration and evidence generation for the nutrition portfolio by translating clinical, economic and patient-centred evidence into actionable Market Access insights.

Evaluated clinical and economic outcomes data to support payer and reimbursement value propositions and strengthen evidence-based strategies. Supported health economic evaluations, cost analyses, and reimbursement research, including the development of cost-of-illness and cost-effectiveness concepts for international reimbursement projects.

Supported German healthcare and reimbursement strategy by evaluating healthcare financing, EMR workflows, and reimbursement considerations for AI applications. Contributed to defining a research roadmap that aligned health economic frameworks with emerging AI applications in the German healthcare ecosystem.

Focused on health economics, pharmacoeconomics, and market access, with coursework in pharmacoeconomic evaluation, health economic modelling, statistics and data analysis, HTA, pricing and reimbursement, healthcare systems, epidemiology, and pharmaceutical market strategy. Applied these methods thr

5-year integrated programme in clinical sciences, research methodology, and patient management